Foundation Medicine Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Cambridge MA United States (2010)
Status: Acquired by Roche (2015)

Organization Overview

First Clinical Trial
2011
NCT01482715
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Flatiron Health, Inc.; Foundation Medicine, Inc. | Foundation Medicine | Foundation Medicine, Inc.